Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung, James A. Wells
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis Group 2021-01-01
Series:mAbs
Assuntos:
Bispecific
neutralizing antibody
knob-in-hole
COVID-19
SARS-CoV-2
Acceso en liña:https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares